-
The University of Tokyo and Chitose Laboratory Drive New Development in Digital Design for Manufacturing Process of Antibody Drugs ―Mathematical model development of cultivation process with full utilization of data from automated experiments―
-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
Media / Editorial
2025.11.24
CHITOSE’s Resource Circulation Business Featured in Forbes Japan and The Chemical Daily
-
CHITOSE Group Announces Capital Increase of JPY 7.3 Billion Scale through Third-Party Allotment
-
Media / Editorial
2024.07.31
Research Paper Published on CHO-MK: Novel Host Cell Line for Biopharmaceutical Manufacturing
-
CHITOSE Group Announces Capital Raising of JPY 1 Billion from SMBC
-
CHITOSE Group, Successfully Concludes Capital Increase of 21M USD Scale through Third-Party Allotment
-
CHITOSE Group, Successfully Concludes Capital Increase of 7M USD Scale from Shiseido and Forms Strategic Partnership ― Accelerate a Microalgae-based Circular Manufacturing in a Cosmetic Industry —
-
CHITOSE Group Obtains Funding from Japanese Government(NEDO) for Green Innovation Fund of 400M USD Scale
